IL127971A - Preservation by creating foam - Google Patents
Preservation by creating foamInfo
- Publication number
- IL127971A IL127971A IL12797197A IL12797197A IL127971A IL 127971 A IL127971 A IL 127971A IL 12797197 A IL12797197 A IL 12797197A IL 12797197 A IL12797197 A IL 12797197A IL 127971 A IL127971 A IL 127971A
- Authority
- IL
- Israel
- Prior art keywords
- foam
- solution
- dispersion
- suspension
- temperature
- Prior art date
Links
- 239000006260 foam Substances 0.000 title claims abstract description 86
- 238000004321 preservation Methods 0.000 title claims abstract description 18
- 230000015572 biosynthetic process Effects 0.000 title description 13
- 238000000034 method Methods 0.000 claims abstract description 87
- 238000001035 drying Methods 0.000 claims abstract description 57
- 239000000243 solution Substances 0.000 claims abstract description 57
- 239000000725 suspension Substances 0.000 claims abstract description 43
- 239000011149 active material Substances 0.000 claims abstract description 29
- 239000006185 dispersion Substances 0.000 claims abstract description 27
- 238000009835 boiling Methods 0.000 claims abstract description 21
- 230000002706 hydrostatic effect Effects 0.000 claims abstract description 13
- 239000013543 active substance Substances 0.000 claims abstract description 5
- 238000003860 storage Methods 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 10
- 229930006000 Sucrose Natural products 0.000 claims description 8
- 238000001704 evaporation Methods 0.000 claims description 8
- 230000008020 evaporation Effects 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 239000005720 sucrose Substances 0.000 claims description 8
- 238000005516 engineering process Methods 0.000 claims description 6
- 235000000346 sugar Nutrition 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 230000009477 glass transition Effects 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 239000002577 cryoprotective agent Substances 0.000 claims 2
- 239000012528 membrane Substances 0.000 claims 2
- 238000001223 reverse osmosis Methods 0.000 claims 2
- 125000000185 sucrose group Chemical group 0.000 claims 2
- 239000000463 material Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- 239000012530 fluid Substances 0.000 description 10
- 102000012011 Isocitrate Dehydrogenase Human genes 0.000 description 8
- 108010075869 Isocitrate Dehydrogenase Proteins 0.000 description 8
- 230000004071 biological effect Effects 0.000 description 8
- 238000005187 foaming Methods 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 239000002502 liposome Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000003801 milling Methods 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 238000013341 scale-up Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 229940088623 biologically active substance Drugs 0.000 description 2
- 238000009529 body temperature measurement Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000006910 ice nucleation Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
- Y10S516/924—Significant dispersive or manipulative operation or step in making or stabilizing colloid system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Colloid Chemistry (AREA)
- Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
- Drying Of Solid Materials (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2179696P | 1996-07-15 | 1996-07-15 | |
| US08/785,473 US5766520A (en) | 1996-07-15 | 1997-01-17 | Preservation by foam formation |
| PCT/US1997/012156 WO1998002240A1 (en) | 1996-07-15 | 1997-07-14 | Preservation by foam formation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL127971A0 IL127971A0 (en) | 1999-11-30 |
| IL127971A true IL127971A (en) | 2001-09-13 |
Family
ID=26695104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12797197A IL127971A (en) | 1996-07-15 | 1997-07-14 | Preservation by creating foam |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5766520A (enExample) |
| EP (1) | EP0914202A4 (enExample) |
| JP (1) | JP2000515856A (enExample) |
| KR (1) | KR100457748B1 (enExample) |
| CN (1) | CN1116104C (enExample) |
| AU (1) | AU714328B2 (enExample) |
| BR (1) | BR9711808A (enExample) |
| CA (1) | CA2260233A1 (enExample) |
| CZ (1) | CZ7999A3 (enExample) |
| DE (1) | DE914202T1 (enExample) |
| EA (1) | EA001138B1 (enExample) |
| HU (1) | HUP9903917A3 (enExample) |
| IL (1) | IL127971A (enExample) |
| NO (1) | NO990158D0 (enExample) |
| NZ (1) | NZ333738A (enExample) |
| PL (1) | PL331174A1 (enExample) |
| TR (1) | TR199900127T2 (enExample) |
| WO (1) | WO1998002240A1 (enExample) |
Families Citing this family (97)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT679088E (pt) * | 1992-09-29 | 2002-12-31 | Inhale Therapeutic Syst | Administracao pulmonar de fragmentos activos de hormona paratiroide |
| US20030113273A1 (en) * | 1996-06-17 | 2003-06-19 | Patton John S. | Methods and compositions for pulmonary delivery of insulin |
| ATE264096T1 (de) | 1994-03-07 | 2004-04-15 | Nektar Therapeutics | Verfahren und mittel zur verabreichung von insulin über die lunge |
| US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| CZ88697A3 (en) | 1994-09-22 | 1997-09-17 | Quadrant Holdings Cambridge | Composition used for re-hydration and nourishment in the course of athletic outputs and processes for preparing thereof |
| US6964771B1 (en) | 1995-06-07 | 2005-11-15 | Elan Drug Delivery Limited | Method for stably incorporating substances within dry, foamed glass matrices |
| US6509146B1 (en) | 1996-05-29 | 2003-01-21 | Universal Preservation Technologies, Inc. | Scalable long-term shelf preservation of sensitive biological solutions and suspensions |
| US6468782B1 (en) * | 1996-12-05 | 2002-10-22 | Quadrant Healthcare (Uk) Limited | Methods of preserving prokaryotic cells and compositions obtained thereby |
| GB9705588D0 (en) | 1997-03-18 | 1997-05-07 | Anglia Research Foundation | Stable particle in liquid formulations |
| US20060116330A1 (en) * | 1997-07-08 | 2006-06-01 | The Iams Company | Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose |
| US20020035071A1 (en) * | 1997-07-08 | 2002-03-21 | Josef Pitha | Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites |
| US8563522B2 (en) * | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
| US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
| US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| AU5459698A (en) * | 1997-11-26 | 1999-06-15 | Universal Preservation Technologies, Inc. | Preservation of sensitive biological samples by vitrification |
| US6306345B1 (en) | 1998-05-06 | 2001-10-23 | Universal Preservation Technologies, Inc. | Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures |
| US6214054B1 (en) | 1998-09-21 | 2001-04-10 | Edwards Lifesciences Corporation | Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby |
| AU2490000A (en) | 1999-01-05 | 2000-07-24 | Universal Preservation Technologies, Inc. | Vacuum control system for foam drying apparatus |
| AP1521A (en) * | 1999-05-04 | 2005-12-22 | Anhydro Ltd | Method for the preservation of viruses and mycoplasma. |
| US6692695B1 (en) | 1999-05-06 | 2004-02-17 | Quadrant Drug Delivery Limited | Industrial scale barrier technology for preservation of sensitive biological materials |
| CA2382061A1 (en) * | 1999-08-19 | 2001-02-22 | Victor Bronshtein | Preservation of bacterial cells at ambient temperatures |
| AU2046101A (en) * | 1999-11-22 | 2001-06-04 | Universal Preservation Technologies, Inc. | Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| AU6124601A (en) | 2000-05-10 | 2001-11-20 | Alliance Pharmaceutical Corporation | Phospholipid-based powders for drug delivery |
| US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
| EP1290390A1 (en) | 2000-06-07 | 2003-03-12 | Universal Preservation Technologies, Inc. | Industrial scale barrier technology for preservation of sensitive biological materials |
| ATE334662T1 (de) * | 2000-06-27 | 2006-08-15 | Hoffmann La Roche | Herstellungsverfahren von arzneizubereitungen |
| US6537666B1 (en) * | 2000-10-23 | 2003-03-25 | Universal Preservation Technologies, Inc. | Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals |
| US7153472B1 (en) * | 2000-11-22 | 2006-12-26 | Quadrant Drug Delivery Limited | Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers |
| US6872357B1 (en) * | 2000-11-22 | 2005-03-29 | Quadrant Drug Delivery Limited | Formulation of preservation mixtures containing sensitive biologicals to be stabilized for ambient temperature storage by drying |
| US20050074867A1 (en) * | 2001-05-07 | 2005-04-07 | Victor Bronshtein | Preservation of competent cells at ambient temperatures |
| US6884866B2 (en) * | 2001-10-19 | 2005-04-26 | Avant Immunotherapeutics, Inc. | Bulk drying and the effects of inducing bubble nucleation |
| US7368102B2 (en) | 2001-12-19 | 2008-05-06 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
| US6878168B2 (en) | 2002-01-03 | 2005-04-12 | Edwards Lifesciences Corporation | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
| JP4902103B2 (ja) | 2002-04-11 | 2012-03-21 | メディミューン・エルエルシー | 凍結乾燥フォームによる生物活性材料の保存 |
| KR101058978B1 (ko) * | 2002-11-01 | 2011-08-23 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 면역원성 조성물 |
| US20050100559A1 (en) * | 2003-11-07 | 2005-05-12 | The Procter & Gamble Company | Stabilized compositions comprising a probiotic |
| US20050100636A1 (en) * | 2003-11-10 | 2005-05-12 | Megan Botteri | [A Low-Calorie Sports Drink For Physically Active Women That is Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Replacing Electrolytes Lost During Periods of Physical Activity] |
| US20050158294A1 (en) * | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| US8877178B2 (en) * | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
| US8894991B2 (en) * | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
| US20050152884A1 (en) * | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
| US9744227B2 (en) | 2004-06-02 | 2017-08-29 | Universal Stabilization Technologies, Inc. | Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof |
| US9469835B2 (en) * | 2004-06-02 | 2016-10-18 | Victor Bronshtein | Preservation by vaporization |
| JP2007277094A (ja) * | 2004-06-29 | 2007-10-25 | Chemo Sero Therapeut Res Inst | 改変ダニ主要アレルゲン含有医薬組成物 |
| CN1993411B (zh) * | 2004-07-30 | 2010-11-24 | 不列颠哥伦比亚大学 | 水状胶体泡沫的制备方法 |
| ATE512211T1 (de) * | 2005-05-31 | 2011-06-15 | Iams Company | Feline probiotische lactobacilli |
| EP1885383B1 (en) * | 2005-05-31 | 2016-09-21 | IAMS Europe B.V. | Feline probiotic bifidobacteria |
| DK1973406T3 (da) | 2005-12-28 | 2014-06-23 | Advanced Bionutrition Corp | Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform |
| US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
| US9453675B2 (en) * | 2006-02-10 | 2016-09-27 | Sp Industries, Inc. | Method of inducing nucleation of a material |
| CN101626682B (zh) * | 2006-10-27 | 2014-04-16 | 爱德华兹生命科学公司 | 用于外科植入的生物组织 |
| WO2008076975A1 (en) | 2006-12-18 | 2008-06-26 | Advanced Bionutrition Corporation | A dry food product containing live probiotic |
| BRPI0808391A2 (pt) | 2007-02-01 | 2014-07-08 | Lams Company | Método para diminuir a inflamação e o estresse em um mamífero, mediante o uso de antimetabólitos de glicose, abacate ou extratos de abacate. |
| KR101557169B1 (ko) * | 2007-05-18 | 2015-10-02 | 메디뮨 엘엘씨 | 냉동 건조 발포체에 의한 생활성 물질의 보존 |
| US9101691B2 (en) * | 2007-06-11 | 2015-08-11 | Edwards Lifesciences Corporation | Methods for pre-stressing and capping bioprosthetic tissue |
| MX2010001054A (es) | 2007-07-26 | 2010-04-21 | Sanofi Pasteur Ltd | Composiciones adyuvantes antigenicas y metodos. |
| CA2699120C (en) * | 2007-09-13 | 2014-07-08 | Enwave Corporation | Apparatus and method for dehydrating biological materials |
| US8357387B2 (en) | 2007-12-21 | 2013-01-22 | Edwards Lifesciences Corporation | Capping bioprosthetic tissue to reduce calcification |
| US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| CN102149813B (zh) | 2008-09-12 | 2015-05-27 | 能波公司 | 利用冷冻和微波使生物材料脱水的设备和方法 |
| ES2908047T3 (es) | 2009-03-27 | 2022-04-27 | Intervet Int Bv | Vacunas en micropartículas para la vacunación oral o nasal y el refuerzo de animales incluidos los peces |
| AU2010254235B2 (en) | 2009-05-26 | 2015-04-02 | Advanced Bionutrition Corporation | Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| US20110064723A1 (en) * | 2009-09-14 | 2011-03-17 | Aridis Pharmaceuticals | Formulation for room temperature stabilization of a live attenuated bacterial vaccine |
| US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
| WO2011094469A2 (en) | 2010-01-28 | 2011-08-04 | Advanced Bionutrition Corporation | Dry glassy composition comprising a bioactive material |
| EP2674174B1 (en) | 2010-03-23 | 2019-10-16 | Edwards Lifesciences Corporation | Methods of conditioning sheet bioprosthetic tissue |
| CA2794135C (en) | 2010-06-17 | 2018-01-02 | Edwards Lifesciences Corporation | Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates |
| US8906601B2 (en) | 2010-06-17 | 2014-12-09 | Edwardss Lifesciences Corporation | Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates |
| ES2676656T3 (es) | 2010-08-13 | 2018-07-23 | Advanced Bionutrition Corp. | Composición estabilizante de almacenamiento en seco para materiales biológicos |
| US9351829B2 (en) | 2010-11-17 | 2016-05-31 | Edwards Lifesciences Corporation | Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability |
| US10238771B2 (en) | 2012-11-08 | 2019-03-26 | Edwards Lifesciences Corporation | Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system |
| PT3003246T (pt) | 2013-05-31 | 2021-02-22 | Victor Bronshtein | Composições poliméricas contendo produtos biofarmacêuticos estáveis à temperatura ambiente e métodos para a formulação dos mesmos |
| US9615922B2 (en) | 2013-09-30 | 2017-04-11 | Edwards Lifesciences Corporation | Method and apparatus for preparing a contoured biological tissue |
| US10959839B2 (en) | 2013-10-08 | 2021-03-30 | Edwards Lifesciences Corporation | Method for directing cellular migration patterns on a biological tissue |
| DK3314007T3 (da) | 2015-06-25 | 2024-04-22 | Native Microbials Inc | Fremgangsmåder, apparater og systemer til analyse af mikroorganismestammer fra komplekse heterogene miljøer til forudsigelse og identificering af funktionelle forbindelser og interaktioner derimellem og udvælgelse og syntese af mikrobielle ensembler baseret derpå |
| US10851399B2 (en) | 2015-06-25 | 2020-12-01 | Native Microbials, Inc. | Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
| WO2017181203A1 (en) | 2016-04-15 | 2017-10-19 | Ascus Biosciences, Inc. | Methods for improving agricultural production of fowl by administration of microbial consortia or purified strains thereof |
| US9938558B2 (en) | 2015-06-25 | 2018-04-10 | Ascus Biosciences, Inc. | Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
| WO2017019273A1 (en) | 2015-07-29 | 2017-02-02 | Advanced Bionutrition Corporation | Stable dry probiotic compositions for special dietary uses |
| CN106434840B (zh) * | 2016-12-02 | 2019-08-09 | 北京中检葆泰生物技术有限公司 | 一种用于微生物法定量检测维生素b12的微孔板、其试剂盒及其制备方法 |
| CA3048248A1 (en) | 2016-12-28 | 2018-07-05 | Ascus Biosciences, Inc. | Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities with tracer analytics, determination of functional relationships and interactions thereof, and synthesis of microbial ensembles including dosed microbial ensembles and inoculative microbial ensembles |
| AU2017386658A1 (en) | 2016-12-28 | 2019-07-25 | Native Microbials, Inc. | Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon |
| CN106701887B (zh) * | 2017-01-03 | 2020-01-17 | 北京中检葆泰生物技术有限公司 | 一种用于微生物法定量检测叶酸的微孔板、其试剂盒及其制备方法 |
| CN106676160B (zh) * | 2017-01-03 | 2020-02-21 | 北京中检葆泰生物技术有限公司 | 一种用于微生物法定量检测泛酸的微孔板、其试剂盒及其制备方法 |
| CN106591415B (zh) * | 2017-01-03 | 2019-12-10 | 北京中检葆泰生物技术有限公司 | 一种用于微生物法定量检测生物素的微孔板、其试剂盒及其制备方法 |
| CN106676161B (zh) * | 2017-01-03 | 2020-01-21 | 北京中检葆泰生物技术有限公司 | 一种用于微生物法定量检测烟酸的微孔板、其试剂盒及其制备方法 |
| US10617756B2 (en) | 2017-01-05 | 2020-04-14 | Shimojani, LLC | Drug regimen for treatment of cerebral ischemia |
| WO2018201154A1 (en) * | 2017-04-28 | 2018-11-01 | Universal Stabilization Technologies, Inc. | Antigenic thermostable polio vaccines & related methods |
| CA3062547A1 (en) | 2017-05-31 | 2018-12-06 | Edwards Lifesciences Corporation | Collagen fibers and articles formed therefrom |
| MX2020003992A (es) | 2017-10-18 | 2020-08-13 | Native Microbials Inc | Aumento de la produccion de aves de corral mediante la administracion de un bioensamblaje sintetico de microbios o cepas purificadas de los mismos. |
| EP3743124B1 (en) | 2018-01-23 | 2024-05-08 | Edwards Lifesciences Corporation | Method for pre-stretching implantable biocompatible materials, and materials and devices produced thereby |
| JP7138336B2 (ja) * | 2018-06-29 | 2022-09-16 | 国立大学法人九州工業大学 | 生体由来の水溶性高分子乾燥品の製造方法及びその製造装置 |
| CN113164258B (zh) | 2018-11-01 | 2024-08-27 | 爱德华兹生命科学公司 | 经导管再生肺动脉瓣 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4642903A (en) * | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
| ATE68524T1 (de) * | 1985-07-09 | 1991-11-15 | Quadrant Bioresources Ltd | Beschuetzung von proteinen und aehnlichem. |
| US5271881A (en) * | 1987-09-28 | 1993-12-21 | Redding Bruce K | Apparatus and method for making microcapsules |
| GB8903593D0 (en) * | 1989-02-16 | 1989-04-05 | Pafra Ltd | Storage of materials |
| US5200399A (en) * | 1990-09-14 | 1993-04-06 | Boyce Thompson Institute For Plant Research, Inc. | Method of protecting biological materials from destructive reactions in the dry state |
| AU659645B2 (en) * | 1991-06-26 | 1995-05-25 | Inhale Therapeutic Systems | Storage of materials |
| US5409703A (en) * | 1993-06-24 | 1995-04-25 | Carrington Laboratories, Inc. | Dried hydrogel from hydrophilic-hygroscopic polymer |
| US5565318A (en) * | 1994-09-02 | 1996-10-15 | Pharmacia Biotech, Inc. | Room temperature stable reagent semi-spheres |
| NZ309841A (en) * | 1995-06-07 | 1999-10-28 | Quadrant Holdings Cambridge | Methods for producing foamed glass matrices (fgm) and compositions obtained thereby |
-
1997
- 1997-01-17 US US08/785,473 patent/US5766520A/en not_active Expired - Fee Related
- 1997-07-14 KR KR10-1999-7000253A patent/KR100457748B1/ko not_active Expired - Fee Related
- 1997-07-14 WO PCT/US1997/012156 patent/WO1998002240A1/en not_active Ceased
- 1997-07-14 PL PL97331174A patent/PL331174A1/xx unknown
- 1997-07-14 DE DE0914202T patent/DE914202T1/de active Pending
- 1997-07-14 TR TR1999/00127T patent/TR199900127T2/xx unknown
- 1997-07-14 NZ NZ333738A patent/NZ333738A/xx unknown
- 1997-07-14 CA CA002260233A patent/CA2260233A1/en not_active Abandoned
- 1997-07-14 JP JP10506201A patent/JP2000515856A/ja not_active Ceased
- 1997-07-14 EA EA199900268A patent/EA001138B1/ru not_active IP Right Cessation
- 1997-07-14 BR BR9711808-7A patent/BR9711808A/pt unknown
- 1997-07-14 CN CN97196422A patent/CN1116104C/zh not_active Expired - Fee Related
- 1997-07-14 EP EP97933415A patent/EP0914202A4/en not_active Withdrawn
- 1997-07-14 IL IL12797197A patent/IL127971A/en not_active IP Right Cessation
- 1997-07-14 HU HU9903917A patent/HUP9903917A3/hu not_active Application Discontinuation
- 1997-07-14 AU AU36606/97A patent/AU714328B2/en not_active Ceased
- 1997-07-14 CZ CZ9979A patent/CZ7999A3/cs unknown
-
1999
- 1999-01-14 NO NO990158A patent/NO990158D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9903917A3 (en) | 2000-06-28 |
| NZ333738A (en) | 2000-09-29 |
| BR9711808A (pt) | 2000-01-18 |
| EP0914202A1 (en) | 1999-05-12 |
| EA001138B1 (ru) | 2000-10-30 |
| CN1226842A (zh) | 1999-08-25 |
| CZ7999A3 (cs) | 1999-11-17 |
| IL127971A0 (en) | 1999-11-30 |
| US5766520A (en) | 1998-06-16 |
| KR20000023779A (ko) | 2000-04-25 |
| KR100457748B1 (ko) | 2004-11-17 |
| JP2000515856A (ja) | 2000-11-28 |
| DE914202T1 (de) | 2000-02-17 |
| EP0914202A4 (en) | 2004-09-01 |
| CA2260233A1 (en) | 1998-01-22 |
| CN1116104C (zh) | 2003-07-30 |
| AU714328B2 (en) | 1999-12-23 |
| HUP9903917A2 (hu) | 2000-03-28 |
| NO990158L (no) | 1999-01-14 |
| TR199900127T2 (xx) | 1999-04-21 |
| EA199900268A1 (ru) | 1999-10-28 |
| NO990158D0 (no) | 1999-01-14 |
| WO1998002240A1 (en) | 1998-01-22 |
| PL331174A1 (en) | 1999-06-21 |
| AU3660697A (en) | 1998-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5766520A (en) | Preservation by foam formation | |
| US6509146B1 (en) | Scalable long-term shelf preservation of sensitive biological solutions and suspensions | |
| EP1032647B1 (en) | Preservation of sensitive biological samples by vitrification | |
| WO1998002240B1 (en) | Preservation by foam formation | |
| EP1750760B1 (en) | Preservation by vaporization | |
| US20030022333A1 (en) | Long-term shelf preservation by vitrification | |
| Hahn-Hägerdal | Water activity: a possible external regulator in biotechnical processes | |
| EP1231837B1 (en) | Preservation of sensitive biological material | |
| BRPI0112638B1 (pt) | Meio de preservação e estocagem para materiais biológicos | |
| AU2001268057A1 (en) | Preservation and storage medium for biological materials | |
| JPH02265984A (ja) | 物質の貯蔵 | |
| CN115024310B (zh) | 一种细胞冻干保存剂及其制备方法 | |
| CN1286725A (zh) | 敏感性生物样品的玻化保质法 | |
| MXPA00005123A (en) | Preservation of sensitive biological samples by vitrification | |
| Salemink | Cell and cell constituent freeze-drying: fundamentals and principles | |
| Rapoporta et al. | Anhydrobiosis in Yeast: Stabilization by Exogenous Lactose1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |